Read More Pharma Industry News Immunic (NASDAQ: IMUX) adds people chief as ENSURE Phase 3 data approach Immunic has appointed Jaa Roberson as its first Chief People Officer as the biotech prepares for pivotal multiple sclerosis data that could move it from clinical development toward regulatory and commercial execution. byPallavi MadhirajuOctober 20, 2026